Focus suppression

Focus suppression is a reduction in the ability to direct and sustain attention toward a chosen task or thought.

As a drug effect it is acute and dose-proportional, fading as the substance wears off, distinct from the attentional deficits of clinical conditions. It ranges from mild concentration drift to a near-total inability to hold a thought or task in mind.

Focus suppression is among the more commonly reported cognitive effects across psychoactive substances. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and MET, and under depressants such as alcohol, 2M2B, and clonidine. It also appears under deliriants such as diphenhydramine, datura, and myristicin, and dissociatives such as ketamine and dextromethorphan.

Focus suppression is felt as a loosening of the attentional grip: thoughts slide away before they can be completed, tasks lose their hold, and deliberate concentration demands effort disproportionate to its results. The mind idles rather than tracks.

It commonly comes with a sense of mental heaviness and a flattened awareness of time passing. Attempting to refocus draws attention to the difficulty itself, compounding the drift. At higher doses, particularly under deliriants and dissociatives, sustained directed thought may become nearly inaccessible, leaving only fragmentary or freely associating cognition.

Focus suppression arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, broadly disrupting cortical signal-to-noise and redirecting attention away from goal-directed processing toward spontaneous or associative thought.
• Depressants — enhance inhibitory signaling, slowing activity in prefrontal regions that support sustained attention.
• Deliriants — block muscarinic acetylcholine receptors; acetylcholine plays a central role in attentional modulation, and its blockade produces pronounced cognitive fragmentation.
• Dissociatives — antagonize NMDA receptors, impairing working memory and the executive processes that anchor attention to a task.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses consistently increase both likelihood and degree. Set and setting matter — mental fatigue, low motivation, or an unstimulating environment worsens it, especially under psychedelics and depressants — as does a disposition toward diffuse attention or a prior history of attentional difficulties.

Expecting it going in tends to make it more salient. Engaging with structured activity before or during a session can reduce its impact considerably.